acrolein has been researched along with Leukemia P388 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, R; Farquhar, D; Khan, S | 1 |
| Amagata, T; Minoura, K; Numata, A | 1 |
2 other study(ies) available for acrolein and Leukemia P388
| Article | Year |
|---|---|
5'-[4-(Pivaloyloxy)-1,3,2-dioxaphosphorinan-2-yl]-2'-deoxy-5-fluorouridine: a membrane-permeating prodrug of 5-fluoro-2'-deoxyuridylic acid (FdUMP).
Topics: Animals; Antimetabolites, Antineoplastic; Cell Division; Cell Membrane; CHO Cells; Cricetinae; Esterases; Fluorodeoxyuridylate; Leukemia P388; Male; Mice; Phosphoric Monoester Hydrolases; Prodrugs; Swine | 1995 |
Cytotoxic metabolites produced by a fungal strain from a Sargassum alga.
Topics: Acrolein; Animals; Antibiotics, Antineoplastic; Chemical Phenomena; Chemistry, Physical; Leukemia P388; Magnetic Resonance Spectroscopy; Mice; Molecular Structure; Penicillium; Phaeophyceae; Pyrones | 1998 |